A case of advanced intrahepatic cholangiocarcinoma successfully treated with chemosensitivity test-guided systemic chemotherapy

作者: Kazumichi Abe , Takeru Wakatsuki , Fumiko Katsushima , Kyoko Monoe , Yukiko Kanno

DOI: 10.3748/WJG.15.5228

关键词:

摘要: Intrahepatic cholangiocarcinoma (ICC) is a relatively rare and highly fatal neoplasm that arises from the biliary epithelium. Prognosis generally poor survival limited to few months. Here we present case of advanced ICC successfully treated by chemosensitivity test-guided systemic chemotherapy combining S-1 cisplatin (CDDP). A 65-year-old woman with liver tumor was referred our hospital on November 21, 2007. Abdominal ultrasonography computed tomography (CT) showed low-density masses 50 15 mm in diameter, respectively segment VIII enlarged lymph node para-aorta. Ultrasonography-guided fine needle biopsy diagnosed tumors as ICC. Since patient inoperable for metastasis, she underwent gemcitabine. Six months after initiation chemotherapy, CT revealed progression pleural dissemination effusion. The admitted anticancer drug sensitivity testing June 9, 2008. Based test results, elected administer CDDP. Two into second treatment, reduction decrease After eight cycles 17 mo diagnosis, alive well no sign recurrence. We conclude may effectively determine appropriate regimen

参考文章(22)
M Grönroos, A L Nieminen, L Kangas, Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Medical biology. ,vol. 62, pp. 338- 343 ,(1984)
Peter E Andreotti, Ian A Cree, Christian M Kurbacher, Diana M Hartmann, Dee Linder, Guy Harel, Ira Gleiberman, Phillip A Caruso, Sharon H Ricks, M Untch, Christian Sartori, Howard W Bruckner, Chemosensitivity Testing of Human Tumors Using a Microplate Adenosine Triphosphate Luminescence Assay: Clinical Correlation for Cisplatin Resistance of Ovarian Carcinoma Cancer Research. ,vol. 55, pp. 5276- 5282 ,(1995)
K Ieta, F Tanaka, T Utsunomiya, H Kuwano, M Mori, CEACAM6 gene expression in intrahepatic cholangiocarcinoma. British Journal of Cancer. ,vol. 95, pp. 532- 540 ,(2006) , 10.1038/SJ.BJC.6603276
H. Kawamura, K. Ikeda, I. Takiyama, M. Terashima, The usefulness of the ATP assay with serum-free culture for chemosensitivity testing of gastrointestinal cancer European Journal of Cancer. ,vol. 33, pp. 960- 966 ,(1997) , 10.1016/S0959-8049(97)00075-0
H Yamaue, H Tanimura, K Noguchi, T Hotta, M Tani, T Tsunoda, M Iwahashi, M Tamai, S Iwakura, Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay. British Journal of Cancer. ,vol. 66, pp. 794- 799 ,(1992) , 10.1038/BJC.1992.362
Nikolas Tsavaris, Christos Kosmas, Panagiotis Gouveris, Kostadinos Gennatas, Aris Polyzos, Despina Mouratidou, Heracles Tsipras, Helias Margaris, George Papastratis, Evanthia Tzima, Nikitas Papadoniou, Gavrilos Karatzas, Efstathios Papalambros, Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer. Investigational New Drugs. ,vol. 22, pp. 193- 198 ,(2004) , 10.1023/B:DRUG.0000011797.09549.53
S.P.M. Crouch, R. Kozlowski, K.J. Slater, J. Fletcher, The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity Journal of Immunological Methods. ,vol. 160, pp. 81- 88 ,(1993) , 10.1016/0022-1759(93)90011-U
K. J. Scanlon, E. M. Newman, Y. Lu, D. G. Priest, Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 83, pp. 8923- 8925 ,(1986) , 10.1073/PNAS.83.23.8923
H Ueno, T Okusaka, M Ikeda, Y Takezako, C Morizane, Phase II study of S-1 in patients with advanced biliary tract cancer. British Journal of Cancer. ,vol. 91, pp. 1769- 1774 ,(2004) , 10.1038/SJ.BJC.6602208